ELEVANCE HEALTH, INC. Long-term Purchase Commitment, Amount
ELEVANCE HEALTH, INC. (ELV) reported Long-term Purchase Commitment, Amount of $481.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-21.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2024-02-21
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for the quarter ending 2023-12-31 was -$73.00M.
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for the quarter ending 2023-09-30 was -$67.00M.
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for the quarter ending 2023-06-30 was -$76.00M.
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for the quarter ending 2023-03-31 was $697.00M, a 28.22% decline year-over-year.
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for fiscal 2023 was $481.00M.
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for fiscal 2021 was $1.05B, a 26.30% decline from fiscal 2020.
- ELEVANCE HEALTH, INC. long-term purchase commitment, amount for fiscal 2020 was $1.43B.
| Period end | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$140.00M derived: sum of 2 quarters · filed 2024-02-21 | -$216.00M derived: sum of 3 quarters · filed 2024-02-21 | $481.00M 10-K · filed 2024-02-21 |
| 2023-09-30 | -$67.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-10-18 | -$143.00M derived: sum of 2 quarters · filed 2023-10-18 | $554.00M 10-Q · filed 2023-10-18 | $485.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2023-06-30 | -$76.00M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-09-29 | $621.00M 10-Q/A · filed 2023-09-29 | $552.00M derived: sum of 3 quarters · filed 2023-10-18 | $480.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2023-03-31 | $697.00M 10-Q · filed 2023-04-19 | $628.00M derived: sum of 2 quarters · filed 2023-10-18 | $556.00M derived: sum of 3 quarters · filed 2023-10-18 | $487.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2022-12-31 | -$69.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | -$141.00M derived: sum of 2 quarters · filed 2023-10-18 | -$210.00M derived: sum of 3 quarters · filed 2023-10-18 | $761.00M 10-Q · filed 2023-10-18 |
| 2022-09-30 | -$72.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-19 | -$141.00M derived: sum of 2 quarters · filed 2022-10-19 | $830.00M 10-Q · filed 2022-10-19 | $777.00M derived: sum of 4 quarters · filed 2022-10-19 |
| 2022-06-30 | -$69.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $902.00M 10-Q · filed 2022-07-20 | $849.00M derived: sum of 3 quarters · filed 2022-07-20 | $787.00M derived: sum of 4 quarters · filed 2022-07-20 |
| 2022-03-31 | $971.00M 10-Q · filed 2022-04-20 | $918.00M derived: sum of 2 quarters · filed 2022-04-20 | $856.00M derived: sum of 3 quarters · filed 2022-04-20 | $799.00M derived: sum of 4 quarters · filed 2022-04-20 |
| 2021-12-31 | -$53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$115.00M derived: sum of 2 quarters · filed 2022-02-16 | -$172.00M derived: sum of 3 quarters · filed 2022-02-16 | $1.05B 10-K · filed 2022-02-16 |
| 2021-09-30 | -$62.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$119.00M derived: sum of 2 quarters · filed 2021-10-20 | $1.10B 10-Q · filed 2021-10-20 | $1.15B derived: sum of 4 quarters · filed 2021-10-20 |
| 2021-06-30 | -$57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | $1.17B 10-Q · filed 2021-07-21 | $1.22B derived: sum of 3 quarters · filed 2021-07-21 | $892.00M derived: sum of 4 quarters · filed 2021-07-21 |
| 2021-03-31 | $1.22B 10-Q · filed 2021-04-21 | $1.27B derived: sum of 2 quarters · filed 2021-04-21 | $949.00M derived: sum of 3 quarters · filed 2021-04-21 | $949.00M derived: sum of 4 quarters · filed 2021-04-21 |
| 2020-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$274.00M derived: sum of 2 quarters · filed 2021-02-18 | -$274.00M derived: sum of 3 quarters · filed 2021-02-18 | $1.43B 10-K · filed 2021-02-18 |
| 2020-09-30 | -$323.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$323.00M derived: sum of 2 quarters · filed 2020-10-28 | $1.38B 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.70B 10-Q · filed 2020-07-29 | ||
| 2020-03-31 | $1.70B 10-Q · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |